Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo, S.
Right arrow Articles by de Vries, E. G.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo, S.
Right arrow Articles by de Vries, E. G.E.
Related Collections
Right arrow Cancer
Right arrow Neuroendocrine
Right arrow Other Psychiatric Disorders

Patients With Carcinoid Syndrome Exhibit Symptoms of Aggressive Impulse Dysregulation

Sascha Russo, MD, Jim C. Boon, MD, Ido P. Kema, PhD, Pax H.B. Willemse, MD, PhD, Johan A. den Boer, MD, PhD, Jakob Korf, PhD and Elisabeth G.E. de Vries, MD, PhD

From the Departments of Biological Psychiatry (S.R., J.C.B., J.S.d.B., J.K.), Laboratory Medicine (I.P.K.), and Medical Oncology (P.H.B.W., E.G.E.d.V), University Hospital Groningen, the Netherlands.



View larger version (7K):

[in a new window]
  		Figure 1. Plasma levels of tryptophan correlate negatively with 24-hour urinary excretion of 5-HIAA in carcinoid patients (p = .001; r = –0.66). Open dots refer to patients not suffering from impulse control dysregulation.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Psychosomatic Society